4-iodoamphetamine has been researched along with mdl 100907 in 1 studies
| Studies (4-iodoamphetamine) | Trials (4-iodoamphetamine) | Recent Studies (post-2010) (4-iodoamphetamine) | Studies (mdl 100907) | Trials (mdl 100907) | Recent Studies (post-2010) (mdl 100907) |
|---|---|---|---|---|---|
| 100 | 4 | 16 | 1,241 | 65 | 539 |
| Protein | Taxonomy | 4-iodoamphetamine (IC50) | mdl 100907 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0048 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, JM; Fantegrossi, WE; Gray, BW; Hansen, M; Kristensen, JL; Smith, DA | 1 |
1 other study(ies) available for 4-iodoamphetamine and mdl 100907
| Article | Year |
|---|---|
Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
Topics: Amphetamines; Animals; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Head Movements; Ketanserin; Male; Mice; Phenethylamines; Piperidines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2015 |